Strepsils Blocked Nose

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Amylmetacresol 0.6mg;  ; Dichlorobenzyl alcohol 1.2mg;  ; Levomenthol 8mg ((Natural or synthetic));  

Disponible depuis:

Reckitt Benckiser (New Zealand) Limited

DCI (Dénomination commune internationale):

Amylmetacresol 0.6 mg

forme pharmaceutique:

Lozenge

Composition:

Active: Amylmetacresol 0.6mg   Dichlorobenzyl alcohol 1.2mg   Levomenthol 8mg ((Natural or synthetic))   Excipient: Eucalyptus oil Indigo carmine Solids from liquid sucrose and liquid glucose: to 2.6g Tartaric acid

Unités en paquet:

Blister pack, PVC/PVDC/Al foil, 6 lozenges

classe:

General sale

Type d'ordonnance:

General sale

Fabriqué par:

BASF PharmaChemikalien GmbH & Co KG

indications thérapeutiques:

Latest Regulatory Activity

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al foil - 6 lozenges - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al foil - 8 lozenges - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al foil - 16 lozenges - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al foil - 24 lozenges - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al foil - 36 lozenges - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al foil - 48 lozenges - 36 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

2007-07-05